Finding the best age to start screening for colorectal cancer
Optimal early colorectal cancer screening initiation
This study is looking at the best age for people between 45 and 49 to start getting screened for colorectal cancer, and it wants to find out how comfortable they feel about it and what might encourage them to participate, while also making sure everyone, no matter their background, has a fair chance to get screened.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-10949013 on NIH RePORTER |
What this research studies
This research investigates the optimal age to begin colorectal cancer screening, particularly focusing on adults aged 45-49. It aims to understand how acceptable screening is for this age group and what factors may influence their participation. The study will also explore potential disparities in screening uptake among different racial and ethnic groups, ensuring that all populations have equal access to screening. By developing a targeted strategy, the research seeks to improve early detection of colorectal cancer in younger adults.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 45-49, particularly those from diverse racial and ethnic backgrounds.
Not a fit: Patients who are under 45 years old or those who have already been diagnosed with colorectal cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection of colorectal cancer, potentially saving lives and reducing mortality rates in younger adults.
How similar studies have performed: Previous research has shown that targeted screening strategies can improve participation rates and outcomes in cancer screening, suggesting that this approach may be effective.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Demb, Joshua Brian — University of California, San Diego
- Study coordinator: Demb, Joshua Brian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.